Director Jay T. Backstrom resigns from Disc Medicine board to focus on Scholar Rock CEO role

Disc Medicine, Inc.

Jay T. Backstrom, M.D., M.P.H., resigns from Board effective June 9, 2023.
Resignation is to focus on his role as Chief Executive Officer of Scholar Rock Holdings.
No disagreement with Disc Medicine's operations, policies, or practices.
Board seat will be vacated; no replacement announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jay T. Backstrom, M.D., M.P.H.

member of the Board of Directors

IRON · Disc Medicine, Inc.

Effective: 2023-06-09
Filed: April 19, 2023, 7:59 PM ET

On April 18, 2023, Jay T. Backstrom, M.D., M.P.H., a member of the Board of Directors (the “Board) of Disc Medicine, Inc. (the “Company”), notified the Company of his resignation from the Board effective as of the close of business on June 9, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jay T. Backstrom, M.D., M.P.H. resigned as member of the Board of Directors at Disc Medicine, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On April 18, 2023, Jay T. Backstrom, M.D., M.P.H., a member of the Board of Directors (the “Board) of Disc Medicine, Inc. (the “Company”), notified the Company of his resignation from the Board effective as of the close of business on June 9, 2023.

View on SEC.gov

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-106433

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.